Frontier Medicines IPO

Frontier Medicines is a precision medicine company that develops breakthrough medicines for patients. Specifically, the company focuses on developing therapies for previously undruggable disease-causing proteins. Through its proprietary Frontier Platform, the company combines scientific approaches that include chemoproteomics, covalent drug discovery, and machine learning. Frontier Medicines was founded in 2018 by Chris Varma Ph.D and headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for Frontier Medicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Frontier Medicines

Forge green plus iconForge green minus icon

What is Frontier Medicines's IPO price?

The IPO price for Frontier Medicines will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Frontier Medicines?

Frontier Medicines is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Frontier Medicines shares pre-IPO?

If you own Frontier Medicines pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Frontier Medicines a publicly traded company?

Frontier Medicines is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Frontier Medicines's funding to date?

Frontier Medicines has raised $255.5MM to date.
Forge green plus iconForge green minus icon

When was Frontier Medicines founded?

Frontier Medicines was founded in 2018.

Who are Frontier Medicines's major investors?

Ra Capital Management
Woodline Partners
Deerfield Management
Deep Track Capital
ArrowMark Partners
Johnson & Johnson Innovation
Droia Ventures
Sphera Funds Management
MPM BioImpact
Driehaus Capital Management
Berkeley Catalyst Fund

Frontier Medicines Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/22/2024 Series C $100MM raised $XXX.XX $XXX.XX
7/19/2021 Series B $88.5MM raised $XXX.XX $XXX.XX
6/25/2019 Series A-1 and A-2 $67MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.